Homology Medicines, Inc.
NASDAQ:FIXX
0.9347 (USD) • At close March 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 77.965 | 39.266 | 33.986 | 108.382 | 217.431 | 53.774 | 38.22 | 51.575 | 11.392 |
| Short Term Investments
| 0 | 43.387 | 141.04 | 47.491 | 0 | 208.614 | 176.517 | 78.084 | 0 |
| Cash and Short Term Investments
| 77.965 | 82.653 | 175.026 | 155.873 | 217.431 | 262.388 | 214.737 | 129.659 | 11.392 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0.4 | 0.4 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.912 | 1.261 | 5.989 | 36.036 | 1.733 | 3.789 | 6.948 | 1.945 | 0.482 |
| Total Current Assets
| 81.877 | 83.914 | 181.015 | 191.909 | 219.564 | 266.577 | 221.685 | 131.603 | 11.987 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 7.092 | 0.65 | 21.641 | 17.859 | 42.899 | 42.716 | 35.637 | 3.154 | 1.956 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 25.814 | 1.953 | 1.274 | 1.274 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.363 | 0 | -47.455 | 0 | 0 | 0 | 1.772 | 2.773 | 0.276 |
| Total Non-Current Assets
| 10.455 | 222.205 | 47.455 | 19.812 | 44.173 | 43.99 | 37.409 | 5.927 | 2.232 |
| Total Assets
| 92.332 | 306.119 | 228.47 | 211.721 | 263.737 | 310.567 | 259.094 | 137.53 | 14.219 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 2.989 | 3.234 | 1.144 | 2.366 | 4.722 | 2.608 | 15.732 | 2.538 | 0.894 |
| Short Term Debt
| 3.097 | 1.318 | 1.561 | 0.246 | 2.501 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 1.156 | 3.208 | 5.632 | 0.809 | 3.684 | 3.341 | 0 |
| Other Current Liabilities
| 7.39 | 7.021 | 18.715 | 11.406 | 9.803 | 8.957 | 6.017 | 2.983 | 5.485 |
| Total Current Liabilities
| 16.465 | 11.573 | 22.576 | 17.226 | 22.658 | 12.374 | 25.433 | 8.862 | 6.378 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 5.636 | 0 | 27.916 | 23.688 | 12.941 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 1.156 | 32.143 | 30.142 | 29.474 | 30.07 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 221.555 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 64.556 | 0 | 0 | 0 | 0 | 9.544 | 9.47 | 0.291 | 17.733 |
| Total Non-Current Liabilities
| 70.192 | 221.555 | 27.916 | 24.844 | 45.084 | 39.686 | 38.944 | 30.36 | 17.733 |
| Total Liabilities
| 86.657 | 233.128 | 50.492 | 42.07 | 67.742 | 52.06 | 64.377 | 39.222 | 24.111 |
| Equity: | |||||||||
| Preferred Stock
| 92.332 | 0 | 0 | 0 | 0 | 0 | 259.094 | 0 | 0 |
| Common Stock
| 0.002 | 0.006 | 0.006 | 0.006 | 0.005 | 0.004 | 0.003 | 0.003 | 0 |
| Retained Earnings
| -234.814 | -542.098 | -429.137 | -424.132 | -328.368 | -199.674 | -97.396 | -40.181 | -10.19 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.005 | -0.404 | -0.007 | 0 | 0.183 | -0.077 | -0.073 | 0 |
| Other Total Stockholders Equity
| 240.487 | 615.088 | 607.513 | 593.784 | 524.358 | 457.994 | 292.187 | 138.56 | 21.937 |
| Total Shareholders Equity
| 5.675 | 72.991 | 177.978 | 169.651 | 195.995 | 258.507 | 194.717 | 98.308 | -9.892 |
| Total Equity
| 0 | 72.991 | 177.978 | 169.651 | 195.995 | 258.507 | 194.717 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 92.332 | 306.119 | 228.47 | 211.721 | 263.737 | 310.567 | 259.094 | 137.53 | 14.219 |